Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR Libraries

Glioblastoma is a severe type of brain tumor with a poor prognosis and few therapy options. Temozolomide (TMZ) is one of these options, however, with limited success, and failure is mainly due to tumor resistance. In this work, genome-wide CRISPR-Cas9 lentiviral screen libraries for gene knockout or...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribeiro Reily Rocha, Clarissa, Reily Rocha, Alexandre, Molina Silva, Matheus, Rodrigues Gomes, Luciana, Teatin Latancia, Marcela, Andrade Tomaz, Marina, de Souza, Izadora, Karolynne Seregni Monteiro, Linda, Frederico Martins Menck, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760831/
https://www.ncbi.nlm.nih.gov/pubmed/33271924
http://dx.doi.org/10.3390/cells9122573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760831/
https://www.ncbi.nlm.nih.gov/pubmed/33271924
http://dx.doi.org/10.3390/cells9122573

Ejemplares similares